Centre Georges Francois Leclerc

Quick facts

Phase 2 pipeline

• chemotherapy: FOLFOX 4
• FOLFIRINOX treatment · Oncology
  FOLFIRINOX is a chemotherapy regimen that combines four different drugs to target rapidly dividing cancer cells.
• Lipidomic analyses
• olaparib, durvalumab, tremelimumab
• OnLife®
• other intravenous chemotherapy drugs

Phase 1 pipeline

• Collection of stool and serum samples
• Durvalumab, Tremelimumab and ,FOLFOX
• FOLFIRINOX Bevacizumab
• Phase I - Mirdametinib - Level 1
• Phase I - Mirdametinib - Level 2
• Phase I - Mirdametinib - Level 3
• Phase I - Mirdametinib - Level 4
• Phase II - Mirdametinib
• serology and ELISPOT test

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Centre Georges Francois Leclerc portfolio CI brief
• Centre Georges Francois Leclerc pipeline updates RSS